João José Joaquim

Prof. Dr. João José Joaquim

Pharmacy, Polytechnic University of Coimbra, Coimbra Health School, Coimbra, Portugal
orcid
Polytechnic University of Coimbra - Health School

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2015 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
CMCristiano Matos
Cristiano Matos
FHFlorence van Hunsel
Florence van Hunsel
João José JoaquimJoão José Joaquim
João José Joaquim
New pharmacovigilance legislation allows consumers to report adverse drug reactions (ADRs) directly to competent authorities in all European Union countries. Consumer reporting is available in Portugal since July 2012. In 2013, the National Pharmacovigilance System (SNF) had received 3461 spontaneous ADR reports, of which only 1.4 % (n = 50) were from consumers. Consumer reporting could be one opportunity to reduce underreporting. The aim of this study was to describe the attitudes and knowledge of the general public regarding spontaneous reporting and the reasons and opinions that can influence consumers’ ADR underreporting. A descriptive-correlational study was performed looking for consumers’ attitudes and knowledge regarding spontaneous reporting. A 6-month survey was conducted from June to November 2013 in general adult consumers from a community pharmacy in Coimbra, Portugal, who used prescribed medicines or over-the-counter (OTC) drugs. Attitudes and opinions were surveyed by personal interview in a closed-answer questionnaire using a Likert scale. Questionnaires from healthcare professionals or incomplete ones were not considered. Data were analyzed using descriptive statistics, chi-square (χ 2) tests, and Spearman’s correlation coefficients. One thousand eighty-four questionnaires were collected (response rate of 81.1 %) and 948 completed were selected for analysis. Of the respondents, 44.1 % never heard about SNF. Younger people and those with a higher education were significantly more likely to be aware of SNF. Only one consumer had previously reported directly an ADR. Reporting ADRs indirectly through a healthcare professional (HCP) was preferred by 62.4 %. The main reasons for consumers reporting spontaneous ADR would be the severity of reactions (81.1 % agreed or strongly agreed) and worries about their situation (73.4 % agreed or strongly agreed). Only weak and moderate correlations were found between studied statements.. Consumers are more likely to do spontaneous report about severe reactions or if they are worried about the symptoms. Tailored and proactive information on ADR reporting and educational interventions on consumers could increase the number of reports from consumers in Portugal.

12 October 2023 in Drug Safety
Verified
Journal Article
Closed access
PDF file
MGMoa Gustafsson
Moa Gustafsson
CMCristiano Matos
Cristiano Matos
João José JoaquimJoão José Joaquim
João José Joaquim
JSJoep Scholl
Joep Scholl
FHFlorence van Hunsel
Florence van Hunsel

31 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MGMoa Gustafsson
Moa Gustafsson
VSVitor Silva
Vitor Silva
CVCarolina Valeiro
Carolina Valeiro
João José JoaquimJoão José Joaquim
João José Joaquim
FHFlorence van Hunsel
Florence van Hunsel
CMCristiano Matos
Cristiano Matos
Opioids are the strongest analgesics available and are crucial in the treatment of acute and chronic pain. The line between these critical medications and how they are used beyond standard therapeutics in cases such as abuse, misuse, and medication errors needs to be understood, as it affects their safety, efficacy, and manner of use. The aim of this systematic review was to identify what is known about the adverse events resulting from the abuse, misuse, and medication errors associated with opioid use. A systematic search was conducted in the PubMed®, Scopus® and, EBSCO® databases to retrieve studies from the inception to December 2023 reporting abuse, misuse, and medication errors associated with medicinal opioid use. Two authors independently screened titles and abstracts and full text according to eligibility using Covidence® software. Full articles were examined by two independent reviewers, and disagreements were resolved by a third reviewer. The risk of bias was assessed by the JBI’s critical appraisal tools. A total of 934 articles were screened by their title and Then, 151 articles were selected for full text screening. Of these, 34 studies were eligible for inclusion in this review. The included studies varied significantly in their population sizes, ranging from 9 individuals to 298,433 patients, and encompassed a diverse demographic, including all ages and both sexes. The studies consistently reported a range of adverse events associated with opioid use. Fentanyl, morphine, oxycodone, tramadol, and hydrocodone were frequently implicated. The data heterogeneity in this field resulted in challenges in drawing conclusions. The review highlights that some opioids, particularly fentanyl, morphine, and oxycodone, are frequently associated with preventable adverse drug reactions, abuse, and medication errors, underscoring the need for robust preventative measures and ongoing research to mitigate opioid-related harm.

8 February 2017 in Drugs & Therapy Perspectives
Verified
Journal Article
Closed access
PDF file
CMCristiano Matos
Cristiano Matos
LRL. Rodrigues
L. Rodrigues
João José JoaquimJoão José Joaquim
João José Joaquim

8 October 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
ARAna Rita Neto Reis
Ana Rita Neto Reis
VSVitor Silva
Vitor Silva
João José JoaquimJoão José Joaquim
João José Joaquim
LVLuís Costa Valadares
Luís Costa Valadares
CMCristiano Matos
Cristiano Matos
FMFernando Moreira
Fernando Moreira
(1) Background: With the increasing incidence of cancer, the need for handling cytotoxic drugs has also grown. However, manipulating these drugs exposes healthcare professionals to significant risks, including occupational exposure to hazardous chemicals. Therefore, it is important to adopt protective measures, including personal protective equipment (PPE) and correct ergonomic practices, to ensure safe drug preparation and minimize health risks for the operators. However, while chemical exposure and PPE have been extensively addressed in the literature, the combined impact of ergonomic practices and protective measures remains insufficiently emphasized, representing a critical gap this review aims to address. Accordingly, the objective of this literature review was to analyze the ergonomic and individual protection practices during the handling of cytostatic drugs and all the implications that bad ergonomic practices and/or poor individual protection have on the operator’s health; (2) Methods: In order to perform this integrative review, a structured literature search was conducted using online databases (Web of Science®, Google Scholar®, and PubMed®) from January 2005 to June 2025. (3) Results: A total of 19 articles were analyzed, with 17 focusing on PPE and 17 on ergonomics. The findings emphasize that PPE, such as gloves, masks, gowns, sleeves and safety glasses, plays a critical role in the safe handling of cytotoxic drugs, particularly when combined with other safety measures. Additionally, maintaining correct ergonomic posture is important in preventing musculoskeletal disorders; (4) Conclusions: This review emphasizes the significance of integrating appropriate PPE use with sound ergonomic procedures. Although PPE is still the secondary line of defense against occupational exposure, ergonomic issues must also be addressed to avoid chronic musculoskeletal problems. Continuous training, rigorous attention to safety procedures, and ergonomic enhancements should be prioritized by healthcare facilities as a key element of occupational safety programs to reduce the short-term and long-term health hazards for personnel handling dangerous drugs.

1 August 2015 in Clinical Therapeutics
Verified
Journal Article
Closed access
ARA. Reis
A. Reis
João José JoaquimJoão José Joaquim
João José Joaquim